Exact Mass: 538.2976

CID 56928080

Betrachotoxinin A, 20-alpha-(2,4-dimethyl-1H-pyrrole-3-carboxylate)

Condurangogenin A

Condurangogenin A; Kondurangogenin A

Fusidate Sodium

Fusidic acid (sodium salt)

C31H47NaO6 (538.327)

D004791 - Enzyme Inhibitors > D011500 - Protein Synthesis Inhibitors C254 - Anti-Infective Agent > C28394 - Topical Anti-Infective Agent D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents C254 - Anti-Infective Agent > C52588 - Antibacterial Agent Fusidic acid sodium salt (Sodium fusidate), a bacteriostatic antibiotic produced from the Fusidium coccineum fungus, belongs to the class of steroids. Fusidic acid sodium salt has no corticosteroid effects. Fusidic acid sodium salt inhibits the growth of bacteria by preventing the release of translation elongation factor G (EF-G) from the ribosome[1][2].

BATRACHOTOXIN

1-{9,12-dihydroxy-6,16-dimethyl-10,19-dioxa-16-azahexacyclo[12.5.3.1⁵,⁹.0¹,¹⁴.0²,¹¹.0⁶,¹¹]tricosa-2,21-dien-22-yl}ethyl 2,4-dimethyl-1H-pyrrole-3-carboxylate

Ulimorelin

5-cyclopropyl-11-[(4-fluorophenyl)methyl]-2,7,8-trimethyl-3,4,5,6,7,8,9,10,11,12,13,14,15,16-tetradecahydro-2H-1,4,7,10,13-benzoxatetrazacyclooctadecine-6,9,12-trione

C30H39FN4O4 (538.2955)

Prolyl-phenylalanyl-arginine-4-nitroanilide

5-Carbamimidamido-N-(2-{[hydroxy(pyrrolidin-2-yl)methylidene]amino}-3-phenylpropanoyl)-2-[(4-nitrophenyl)amino]pentanimidate

C26H34N8O5 (538.2652)

Colossolactone F

(+)-Colossolactone F

Alangionoside O

Colossolactone G

(+)-Crocacin A

Integristerone A 25-acetate

Sanjoinine G2

C30H42N4O5 (538.3155)

Dysinosin D

C25H42N6O7 (538.3115)

Colossolactone VIII

Asn His Ile Arg

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-methylpentanamido]-5-carbamimidamidopentanoic acid

C22H38N10O6 (538.2976)

His Val Gln Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-methylbutanamido]-4-carbamoylbutanamido]-5-carbamimidamidopentanoic acid

C22H38N10O6 (538.2976)

Tyr Gln Thr Lys

(2S)-6-amino-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-4-carbamoylbutanamido]-3-hydroxybutanamido]hexanoic acid

Gln Val His Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-methylbutanamido]-3-(1H-imidazol-4-yl)propanamido]-5-carbamimidamidopentanoic acid

C22H38N10O6 (538.2976)

Asn Ala Leu Ala His

C23H38N8O7 (538.2863)

Thr Tyr Leu Glu

C25H38N4O9 (538.2639)

C28H42O10_4H-Cyclopenta[a]cyclopropa[f]cycloundecen-4-one, 4a-(acetyloxy)-9-[(hexopyranosyloxy)methyl]-1,1a,4a,5,6,7,7a,10,11,11a-decahydro-7-hydroxy-1,1,3,6-tetramethyl-, (8E)

NCGC00380865-01_C28H42O10_4H-Cyclopenta[a]cyclopropa[f]cycloundecen-4-one, 4a-(acetyloxy)-9-[(hexopyranosyloxy)methyl]-1,1a,4a,5,6,7,7a,10,11,11a-decahydro-7-hydroxy-1,1,3,6-tetramethyl-, (8E)-

(2S)-6-amino-2-[(2S)-6-amino-2-[(2S,3R)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-3-hydroxybutanamido]hexanamido]hexanoic acid

C25H42N6O7 (538.3115)

Tyr Thr Lys Gln

(2S)-2-[(2S)-6-amino-2-[(2S,3R)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-3-hydroxybutanamido]hexanamido]-4-carbamoylbutanoic acid

Tyr Thr Gln Lys

(2S)-6-amino-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-3-hydroxybutanamido]-4-carbamoylbutanamido]hexanoic acid

(-)-Batrachotoxin

PG(20:1(11Z)/0:0)

1-(11Z-eicosenoyl)-glycero-3-phospho-(1-sn-glycerol)

C26H51O9P (538.3271)

TMC-1C

(2E,4E)-N-[(3S,4R)-3,4-dihydroxy-3-[(1E,3E,5E)-7-[(2-hydroxy-5-oxocyclopent-1-en-1-yl)amino]-7-oxohepta-1,3,5-trienyl]-6-oxocyclohex-1-en-1-yl]-4,6-dimethyldeca-2,4-dienamide

C30H38N2O7 (538.2679)

A polyene antibiotic that is TMC-1A in which the 2,4-dimethyloct-2-enoyl group has been replaced by an (E,E)-4,6-dimethyldeca-2,4-dienoyl group. TMC-1C is an antitumour antibiotic isolated from Streptomyces sp. A-230.

LPG 20:1

1-(11Z-eicosenoyl)-glycero-3-phospho-(1-sn-glycerol)

C26H51O9P (538.3271)

ST 29:3;O9

22beta-acetoxy-2beta,3beta,11alpha,14alpha,20,25-hexahydroxy-5beta-cholest-7-en-6-one

Zoanthone A

25-acetoxy-2beta,3beta,11alpha,14alpha,20R,22R-hexahydroxy-5beta-cholest-7-en-6-one

1,1-[(5E)-5-Methyl-7-oxo-5-undecene-1,11-diyl] Bis

C26H34N8O5 (538.2652)

(5-Amino-2-butyl-3-benzofuranyl)[4-[3-(dibutylamino)propoxy]phenyl]oxalate

WAY-100635 (maleate salt)

9-BENZHYDRYLIDENE-10-ANTHRONE

C30H42N4O5 (538.3155)

1,3,3-trimethyl-2-[2-[3-[2-(1,3,3-trimethylindol-1-ium-2-yl)ethenyl]-2H-pyran-5-ylidene]ethylidene]indole,tetrafluoroborate

C31H35BF4N2O (538.2778)

Pentolinium Tartrate

C23H42N2O12 (538.2738)

C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C66886 - Nicotinic Antagonist D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D005730 - Ganglionic Blockers D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents

LITHIUM NIOBIUM TERT-BUTOXIDE

C24H54LiNbO6 (538.3144)

nafiverine

C34H38N2O4 (538.2831)

C78272 - Agent Affecting Nervous System > C29698 - Antispasmodic Agent

1,4-BIS[BIS(3,5-DIMETHYLPHENYL)PHOSPHINO]BUTANE

C36H44P2 (538.2918)

Ulimorelin

C30H39FN4O4 (538.2955)

C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C76358 - Growth Hormone-Releasing Hormone Analogue C78281 - Agent Affecting Musculoskeletal System > C1935 - Anticachexia Agent > C84868 - Ghrelin Peptide Analogue

Prolyl-phenylalanyl-arginine-4-nitroanilide

5-Carbamimidamido-N-(2-{[hydroxy(pyrrolidin-2-yl)methylidene]amino}-3-phenylpropanoyl)-2-[(4-nitrophenyl)amino]pentanimidate

C26H34N8O5 (538.2652)

Cusperin A

C26H42N4O8 (538.3002)

Sucrose-2,4-di-(3-methyl)pentanoate

CID 5478936

[(3E,10E)-13-hydroxy-3,6,6,14-tetramethyl-2-oxo-10-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]-1-tricyclo[10.3.0.05,7]pentadeca-3,10-dienyl] acetate

Ajubractin D

A diterpenoid isolated from the aerial parts of Ajuga bracteosa.

14-hydro-15-hydroxyajugachin A

(2E,4E)-N-[(3S,4R)-3,4-dihydroxy-3-[(1E,3E,5E)-7-[(2-hydroxy-5-oxocyclopent-1-en-1-yl)amino]-7-oxohepta-1,3,5-trienyl]-6-oxocyclohex-1-en-1-yl]-4,6-dimethyldeca-2,4-dienamide

C30H38N2O7 (538.2679)

1-(11Z-eicosenoyl)-glycero-3-phospho-(1-sn-glycerol)

C26H51O9P (538.3271)

TG(30:8)

WAY-100635 maleate is a potent and selective 5-hydroxytryptamine 1A (5-HT1A) receptor antagonist with an IC50 value of 0.91 nM and Ki value of 0.39 nM. WAY-100635 maleate has pIC50 values for 5-HT1A and α1-adrenergic receptors of 8.9 and 6.6, respectively. WAY-100635 maleate is also a potent dopamine D4 receptor agonist[1][2][3].

methyl (6r)-6-[(1r,2s,3ar,5ar,9as,11ar)-2-(acetyloxy)-3a,6,6,9a,11a-pentamethyl-7,10-dioxo-1h,2h,3h,4h,5h,5ah,11h-cyclopenta[a]phenanthren-1-yl]-2-methylhept-2-enoate

6,9-dihydroxy-7-methyl-14-(3-methylbut-2-en-1-yl)-4-{[7-(3-methylbut-2-en-1-yl)-1h-indol-3-yl]methyl}-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-5,10(15),11,13-tetraen-3-one

C33H38N4O3 (538.2944)

(9r,13r,14r,16r,17r,19s)-19-hydroxy-8,8,13,17-tetramethyl-16-[(1s)-1-(5-methyl-6-oxo-2,3-dihydropyran-2-yl)ethyl]-6-oxo-7-oxatetracyclo[10.7.0.0³,⁹.0¹³,¹⁷]nonadeca-1(12),2,4-trien-14-yl acetate

(9r,13r,14r,16r,17r,19s)-19-hydroxy-8,8,13,17-tetramethyl-16-[(1s)-1-(5-methyl-6-oxo-2,3-dihydropyran-2-yl)ethyl]-6-oxo-7-oxatetracyclo[10.7.0.0³,⁹.0¹³,¹⁷]nonadeca-1(12),2,4-trien-14-yl acetate

1,3-oxazol-5-yl({4-[(1r,3s,4r,5s)-1,3,4,5-tetrahydroxyhexyl]-1,3-oxazol-2-yl})methyl 13-methyltetradecanoate

C28H46N2O8 (538.3254)

(1r,2s,4ar,5s,6r,8s,8ar)-5-[(2s,3as,5r,6ar)-5-ethoxy-hexahydrofuro[2,3-b]furan-2-yl]-2,8-bis(acetyloxy)-5,6-dimethyl-hexahydro-2h-spiro[naphthalene-1,2'-oxiran]-8a-ylmethyl acetate

(2r)-n-[(2s)-1-[(2s,3ar,5s,6s,7as)-2-{[2-(1-carbamimidoyl-2,5-dihydropyrrol-3-yl)ethyl]carbamoyl}-5,6-dihydroxy-octahydroindol-1-yl]-3-methyl-1-oxobutan-2-yl]-3-hydroxy-2-methoxypropanimidic acid

C25H42N6O7 (538.3115)

8-(acetyloxy)-8a-[(acetyloxy)methyl]-5-{hexahydrofuro[2,3-b]furan-2-yl}-3-hydroxy-5,6-dimethyl-hexahydro-2h-spiro[naphthalene-1,2'-oxiran]-2-yl 2-methylpropanoate

(2r,3r)-2-[(1s,3as,5as,7r,8s,9ar,9br,11ar)-3a,5a,7,8-tetrahydroxy-9a,11a-dimethyl-5-oxo-1h,2h,3h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-2,6-dihydroxy-6-methylheptan-3-yl acetate

(9s,10r,13s,16r,17r,18s)-10-hydroxy-8,8,13,17-tetramethyl-16-[(1s)-1-[(2s)-5-methyl-6-oxo-2,3-dihydropyran-2-yl]ethyl]-6-oxo-7-oxatetracyclo[10.7.0.0³,⁹.0¹³,¹⁷]nonadeca-1(12),2,4-trien-18-yl acetate

(9s,10r,13s,16r,17r,18s)-10-hydroxy-8,8,13,17-tetramethyl-16-[(1s)-1-[(2s)-5-methyl-6-oxo-2,3-dihydropyran-2-yl]ethyl]-6-oxo-7-oxatetracyclo[10.7.0.0³,⁹.0¹³,¹⁷]nonadeca-1(12),2,4-trien-18-yl acetate

(2s,3r,4s,5r,6r)-2-{[(1s,3r,4r)-3,4-dihydroxy-4-[(1e,3r)-3-hydroxybut-1-en-1-yl]-3,5,5-trimethylcyclohexyl]oxy}-6-({[(2r,3s,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}methyl)oxane-3,4,5-triol

(1r,2s,3s,4ar,5s,6r,8s,8ar)-5-[(2r,3ar,6as)-hexahydrofuro[2,3-b]furan-2-yl]-8-(acetyloxy)-8a-[(acetyloxy)methyl]-3-hydroxy-5,6-dimethyl-hexahydro-2h-spiro[naphthalene-1,2'-oxiran]-2-yl 2-methylpropanoate

(1r,2s,3s,4ar,5s,6r,8s,8ar)-5-[(2r,3ar,6as)-hexahydrofuro[2,3-b]furan-2-yl]-8-(acetyloxy)-8a-[(acetyloxy)methyl]-3-hydroxy-5,6-dimethyl-hexahydro-2h-spiro[naphthalene-1,2'-oxiran]-2-yl 2-methylpropanoate

3-[(1r,2r,3s,5r,6r,10s,11s,13r)-3-acetyl-2,6,10-trimethyl-5-[(1z)-1-[(2r,4r)-4-methyl-5-oxooxolan-2-yl]prop-1-en-2-yl]-7-oxo-11-(prop-1-en-2-yl)-14-oxatetracyclo[7.5.0.0¹,¹³.0²,⁶]tetradec-8-en-10-yl]propanoic acid

3-[(1r,2r,3s,5r,6r,10s,11s,13r)-3-acetyl-2,6,10-trimethyl-5-[(1z)-1-[(2r,4r)-4-methyl-5-oxooxolan-2-yl]prop-1-en-2-yl]-7-oxo-11-(prop-1-en-2-yl)-14-oxatetracyclo[7.5.0.0¹,¹³.0²,⁶]tetradec-8-en-10-yl]propanoic acid

n-[5-({7-hydroxy-3-[(1-hydroxy-3-methylbut-2-en-1-ylidene)amino]-5,7a-dimethyl-1-oxo-6,7-dihydro-5h-pyrrolizin-2-yl}methyl)-2,6a-dimethyl-6-oxo-1ah,2h,6bh-oxireno[2,3-a]pyrrolizin-4-yl]-3-methylbut-2-enimidic acid

n-[5-({7-hydroxy-3-[(1-hydroxy-3-methylbut-2-en-1-ylidene)amino]-5,7a-dimethyl-1-oxo-6,7-dihydro-5h-pyrrolizin-2-yl}methyl)-2,6a-dimethyl-6-oxo-1ah,2h,6bh-oxireno[2,3-a]pyrrolizin-4-yl]-3-methylbut-2-enimidic acid

(2S,3S)-N-[(1S)-1-carbamoyl-3-methyl-butyl]-2-[[(2S)-2-dimethylamino-3-phenyl-propanoyl]amino]-3-(4-formylphenoxy)-4-methyl-valeramide

(2S,3S)-N-[(1S)-1-carbamoyl-3-methyl-butyl]-2-[[(2S)-2-dimethylamino-3-phenyl-propanoyl]amino]-3-(4-formylphenoxy)-4-methyl-pentanamide; (2S,3S)-N-[(2S)-1-amino-4-methyl-1-oxo-pentan-2-yl]-2-[[(2S)-2-dimethylamino-3-phenyl-propanoyl]amino]-3-(4-methanoylphenoxy)-4-methyl-pentanamide; (2S,3S)-N-[(1S)-1-carbamoyl-3-methylbutyl]-2-[[(2S)-2-dimethylamino-1-oxo-3-phenylpropyl]amino]-3-(4-formylphenoxy)-4-methylpentanamide; (2S,3S)-N-[(2S)-1-amino-4-methyl-1-oxopentan-2-yl]-2-[[(2S)-2-dimethylamino-3-phenylpropanoyl]amino]-3-(4-formylphenoxy)-4-methylpentanamide

C30H42N4O5 (538.3155)

{"Ingredient_id": "HBIN006727","Ingredient_name": "(2S,3S)-N-[(1S)-1-carbamoyl-3-methyl-butyl]-2-[[(2S)-2-dimethylamino-3-phenyl-propanoyl]amino]-3-(4-formylphenoxy)-4-methyl-valeramide","Alias": "(2S,3S)-N-[(1S)-1-carbamoyl-3-methyl-butyl]-2-[[(2S)-2-dimethylamino-3-phenyl-propanoyl]amino]-3-(4-formylphenoxy)-4-methyl-pentanamide; (2S,3S)-N-[(2S)-1-amino-4-methyl-1-oxo-pentan-2-yl]-2-[[(2S)-2-dimethylamino-3-phenyl-propanoyl]amino]-3-(4-methanoylphenoxy)-4-methyl-pentanamide; (2S,3S)-N-[(1S)-1-carbamoyl-3-methylbutyl]-2-[[(2S)-2-dimethylamino-1-oxo-3-phenylpropyl]amino]-3-(4-formylphenoxy)-4-methylpentanamide; (2S,3S)-N-[(2S)-1-amino-4-methyl-1-oxopentan-2-yl]-2-[[(2S)-2-dimethylamino-3-phenylpropanoyl]amino]-3-(4-formylphenoxy)-4-methylpentanamide","Ingredient_formula": "C30H42N4O5","Ingredient_Smile": "NA","Ingredient_weight": "538.68","OB_score": "15.65957604","CAS_id": "107494-21-3","SymMap_id": "SMIT03939","TCMID_id": "NA","TCMSP_id": "MOL001538","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

(2r,4's,5s,6r,8'r,10'z,13'r,14's,15'z)-6-ethyl-14',21'-dihydroxy-5,11',13',22'-tetramethyl-3',7',19'-trioxaspiro[oxane-2,6'-tetracyclo[15.6.1.1⁴,⁸.0²⁰,²⁴]pentacosane]-1'(24'),10',15',17',20',22'-hexaen-2'-one

(2r,4's,5s,6r,8'r,10'z,13'r,14's,15'z)-6-ethyl-14',21'-dihydroxy-5,11',13',22'-tetramethyl-3',7',19'-trioxaspiro[oxane-2,6'-tetracyclo[15.6.1.1⁴,⁸.0²⁰,²⁴]pentacosane]-1'(24'),10',15',17',20',22'-hexaen-2'-one

(z,2e,4e,10e)-7,9-dimethoxy-n-[(1e,4e)-5-[(2-methoxy-2-oxoethyl)-c-hydroxycarbonimidoyl]penta-1,4-dien-1-yl]-3,6,8-trimethyl-11-phenylundeca-2,4,10-trienimidic acid

2-{3a,7,8-trihydroxy-9a,11a-dimethyl-5-oxo-1h,2h,3h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}-2,6-dihydroxy-6-methylheptan-3-yl 2-hydroxyacetate

n-[5-({6-hydroxy-3-[(1-hydroxy-3-methylbut-2-en-1-ylidene)amino]-5,7a-dimethyl-1-oxo-6,7-dihydro-5h-pyrrolizin-2-yl}methyl)-2,6a-dimethyl-6-oxo-1ah,2h,6bh-oxireno[2,3-a]pyrrolizin-4-yl]-3-methylbut-2-enimidic acid

n-[5-({6-hydroxy-3-[(1-hydroxy-3-methylbut-2-en-1-ylidene)amino]-5,7a-dimethyl-1-oxo-6,7-dihydro-5h-pyrrolizin-2-yl}methyl)-2,6a-dimethyl-6-oxo-1ah,2h,6bh-oxireno[2,3-a]pyrrolizin-4-yl]-3-methylbut-2-enimidic acid

1-hydroxy-8,8,13-trimethyl-16-[1-(5-methyl-6-oxo-2,3-dihydropyran-2-yl)ethyl]-17-methylidene-6-oxo-7-oxatetracyclo[10.7.0.0³,⁹.0¹³,¹⁸]nonadeca-2,4-dien-10-yl acetate

(1s,9s,10r,12s,13r,16s,18s)-1-hydroxy-8,8,13-trimethyl-16-[(1r)-1-[(2r)-5-methyl-6-oxo-2,3-dihydropyran-2-yl]ethyl]-17-methylidene-6-oxo-7-oxatetracyclo[10.7.0.0³,⁹.0¹³,¹⁸]nonadeca-2,4-dien-10-yl acetate

(1s,9s,10r,12s,13r,16s,18s)-1-hydroxy-8,8,13-trimethyl-16-[(1r)-1-[(2r)-5-methyl-6-oxo-2,3-dihydropyran-2-yl]ethyl]-17-methylidene-6-oxo-7-oxatetracyclo[10.7.0.0³,⁹.0¹³,¹⁸]nonadeca-2,4-dien-10-yl acetate

(9r,13r,14r,16r,17r)-16-[(1s)-1-[(2r,3s)-3-hydroxy-5-methyl-6-oxo-2,3-dihydropyran-2-yl]ethyl]-8,8,13,17-tetramethyl-6-oxo-7-oxatetracyclo[10.7.0.0³,⁹.0¹³,¹⁷]nonadeca-1(12),2,4-trien-14-yl acetate

(9r,13r,14r,16r,17r)-16-[(1s)-1-[(2r,3s)-3-hydroxy-5-methyl-6-oxo-2,3-dihydropyran-2-yl]ethyl]-8,8,13,17-tetramethyl-6-oxo-7-oxatetracyclo[10.7.0.0³,⁹.0¹³,¹⁷]nonadeca-1(12),2,4-trien-14-yl acetate

(1ar,2r,3s,3as,5r,6r,7ar,7bs)-2-[(2e)-but-2-en-2-yl]-3-[(1e,3e,5s,6s)-5,7-dihydroxy-4,6-dimethylhepta-1,3-dien-1-yl]-6-hydroxy-1a,6-dimethyl-octahydronaphtho[1,2-b]oxiren-5-yl 2-phenylacetate

(1r,4s,7s,9s)-6,9-dihydroxy-7-methyl-14-(3-methylbut-2-en-1-yl)-4-{[7-(3-methylbut-2-en-1-yl)-1h-indol-3-yl]methyl}-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-5,10(15),11,13-tetraen-3-one

(1r,4s,7s,9s)-6,9-dihydroxy-7-methyl-14-(3-methylbut-2-en-1-yl)-4-{[7-(3-methylbut-2-en-1-yl)-1h-indol-3-yl]methyl}-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-5,10(15),11,13-tetraen-3-one

C33H38N4O3 (538.2944)

2-(but-2-en-2-yl)-3-(5,7-dihydroxy-4,6-dimethylhepta-1,3-dien-1-yl)-6-hydroxy-1a,6-dimethyl-octahydronaphtho[1,2-b]oxiren-5-yl 2-phenylacetate

methyl (2z,6r)-6-[(1r,3r,4r,5s,7r,11r,16s)-5-(acetyloxy)-3,7,12,12,16-pentamethyl-13-oxo-18-oxapentacyclo[13.2.1.0³,⁷.0⁸,¹⁷.0¹¹,¹⁶]octadeca-8(17),14-dien-4-yl]-2-methylhept-2-enoate

(1r,3br,4s,5r,5ar,9ar,9br,11as)-5-hydroxy-1-[(5s)-5-methoxy-2-oxo-5h-furan-3-yl]-3b,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,4h,5h,5ah,9bh,10h,11h-cyclopenta[a]phenanthren-4-yl 3-methylbut-2-enoate

(1s,2r,4r)-1-[(1e,3r)-3-{[(2r,3r,4s,5s,6r)-3-{[(2s,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}but-1-en-1-yl]-2,6,6-trimethylcyclohexane-1,2,4-triol

(1s,2r,4r)-1-[(1e,3r)-3-{[(2r,3r,4s,5s,6r)-3-{[(2s,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}but-1-en-1-yl]-2,6,6-trimethylcyclohexane-1,2,4-triol

2-{3a,5a,7,8-tetrahydroxy-9a,11a-dimethyl-5-oxo-1h,2h,3h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}-3,6-dihydroxy-6-methylheptan-2-yl acetate

(6s)-6-[(1s)-1-[(1s,3s,3ar,3br,5r,5ar,9ar,9bs,11as)-1,3,3a,5,5a-pentahydroxy-9a,11a-dimethyl-9-oxo-decahydro-2h-cyclopenta[a]phenanthren-1-yl]-1-hydroxyethyl]-3-(hydroxymethyl)-4-methyl-5,6-dihydropyran-2-one

(6s)-6-[(1s)-1-[(1s,3s,3ar,3br,5r,5ar,9ar,9bs,11as)-1,3,3a,5,5a-pentahydroxy-9a,11a-dimethyl-9-oxo-decahydro-2h-cyclopenta[a]phenanthren-1-yl]-1-hydroxyethyl]-3-(hydroxymethyl)-4-methyl-5,6-dihydropyran-2-one

(2r,3r)-2-[(1s,3as,5as,7s,8r,9ar,9br,11ar)-3a,5a,7,8-tetrahydroxy-9a,11a-dimethyl-5-oxo-1h,2h,3h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-3,6-dihydroxy-6-methylheptan-2-yl acetate

n-[(1ar,2s,6as,6bs)-5-{[(5s,7r,7as)-7-hydroxy-3-[(1-hydroxy-3-methylbut-2-en-1-ylidene)amino]-5,7a-dimethyl-1-oxo-6,7-dihydro-5h-pyrrolizin-2-yl]methyl}-2,6a-dimethyl-6-oxo-1ah,2h,6bh-oxireno[2,3-a]pyrrolizin-4-yl]-3-methylbut-2-enimidic acid

n-[(1ar,2s,6as,6bs)-5-{[(5s,7r,7as)-7-hydroxy-3-[(1-hydroxy-3-methylbut-2-en-1-ylidene)amino]-5,7a-dimethyl-1-oxo-6,7-dihydro-5h-pyrrolizin-2-yl]methyl}-2,6a-dimethyl-6-oxo-1ah,2h,6bh-oxireno[2,3-a]pyrrolizin-4-yl]-3-methylbut-2-enimidic acid

(2r,3r,4s,5s,6r)-2-{[(1s,3r,4r)-3,4-dihydroxy-4-[(1e)-3-hydroxybut-1-en-1-yl]-3,5,5-trimethylcyclohexyl]oxy}-6-({[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}methyl)oxane-3,4,5-triol

(2r,3r)-2-[(1s,3as,5ar,7r,8s,9ar,9br,11ar)-3a,7,8-trihydroxy-9a,11a-dimethyl-5-oxo-1h,2h,3h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-2,6-dihydroxy-6-methylheptan-3-yl 2-hydroxyacetate

(2r,3r)-2-[(1s,3as,5ar,7r,8s,9ar,9br,11ar)-3a,7,8-trihydroxy-9a,11a-dimethyl-5-oxo-1h,2h,3h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-2,6-dihydroxy-6-methylheptan-3-yl 2-hydroxyacetate